Keros Therapeutics vs OrsoBio
Keros Therapeutics
Keros is dedicated to the discovery and development of novel therapeutics for multiple disorders
123 employees · est. 2016 · Lexington, United States
OrsoBio
Advancing first-in-class therapies to restore energy homeostasis
18 employees · est. 2021 · Palo Alto, United States
Keros Therapeutics is the older company (2016 vs 2021); Keros Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Keros Therapeutics | OrsoBio |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2021 |
| Headquarters | ||
| Headquarters | Lexington, United States | Palo Alto, United States |
| Employees | ||
| Employees | 123 larger | 18 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | IPO | Series A |
| Total Funding | ||
| Total Funding | $379.50M | $62.30M |
| Funding Rounds | ||
| Funding Rounds | 6 | 2 |
| Services | ||
| Services | Development of novel therapeutics, Modulation of TGF-beta signaling, Clinical trials for drug candidates, Hematology and neuromuscular franchises | Developing first-in-class therapies, Targeting energy metabolism pathways, Restoring energy homeostasis |
| Target Customers | ||
| Target Customers | Patients with TGF-beta related disorders, Healthcare professionals, Research institutions, Neuromuscular disorder specialists | Patients with severe metabolic disorders, Individuals with obesity and diabetes, Healthcare providers focused on metabolic health |
| Taxonomy | ||
| Taxonomy | BiopharmaceuticalTherapeutics DevelopmentTGF-ß SignalingHematologic DisordersMusculoskeletal DisordersClinical-stage Company +9 | First-in-class TherapiesEnergy HomeostasisMetabolic DisordersType 2 DiabetesSevere DyslipidemiasLipodystrophies +9 |
| Website | ||
| Website | kerostx.com | orsobio.com |
About Keros Therapeutics
Keros Therapeutics, founded in 2016, is a biotechnology innovator headquartered in the United States and operates across several key industries, including Biotechnology, Health Care, Health and Wellness, and Pharmaceutical. The company is dedicated to the discovery and development of novel therapeu...
About OrsoBio
OrsoBio, founded in 2021, is a United States-based, clinical-stage biopharmaceutical company aiming to transform the treatment of severe metabolic disorders. Guided by its slogan, "Advancing first-in-class therapies to restore energy homeostasis", the company focuses on innovative treatments for con...
Also comparing in this category
Comparing more than these two?
Get Keros Therapeutics, OrsoBio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Keros Therapeutics compare?
A PDF of Keros Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Keros Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Keros Therapeutics on 18 Mar 2026, and OrsoBio on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
